Celyad Announces 2016 Financial Calendar
MONT-SAINT-GUIBERT, Belgium, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a leader in the discovery and development of engineered cell therapies, with clinical programs in cardiovascular disease and immuno-oncology, today announced 2016 Financial Calendar. Yearly end financial report 2015: 24 March 2016Annual General Meeting: 5 May 2016Q1 2016 Business update: 19 May 2016Half year results H1 2016: 25 August 2016Q3 2016 Business update: 18 November Read more [...]